Publications by authors named "Yanou Engelen"

Claim this Profile
P
Preclinical toxicological assessment of an α-galactosylceramide-adjuvanted mRNA cancer vaccine in Wistar Han rats and domestic pigs.
Sofie Meulewaeter, Margo De Velder, Diethard Reckelbus, Kevin Mwangi, Thomas Ehouarne, Yanou Engelen

Mol Ther Methods Clin Dev· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing high-intensity focused ultrasound-induced immunogenic cell-death using passive cavitation mapping as a monitoring tool.
Yanou Engelen, Dmitri V Krysko, Iuliia Effimova, Karine Breckpot, Michel Versluis

J Control Release· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanomedicine to aid immunogenic cell death (ICD)-based anticancer therapy.
Robin Demuynck, Yanou Engelen, André G Skirtach, Stefaan C De Smedt, Ine Lentacker

Trends Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alpha-galactosylceramide improves the potency of mRNA LNP vaccines against cancer and intracellular bacteria.
Sofie Meulewaeter, Ilke Aernout, Joke Deprez, Yanou Engelen, Margo De Velder

J Control Release· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Laser-induced vapor nanobubbles for B16-F10 melanoma cell killing and intracellular delivery of chemotherapeutics.
Jana Ramon, Yanou Engelen, Herlinde De Keersmaecker, Ilia Goemaere, Deep Punj

J Control Release· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis